Priced to Fail: How Defense Tech Dilution Rounds Quietly Destroy Founder Economics

Most founders running defense tech companies understand they're playing a longer game than their SaaS counterparts. What fewer of them model out early enough is how that longer timeline compounds against them in the cap table.

Photo by Aseem Borkar on Pexels.

The average defense tech startup takes seven to ten years to reach a meaningful exit. Compare that to three to five years for a typical enterprise software company. Multiply the timeline and you get more rounds, more dilution events, and a founder ownership stack that, by Series C or D, often sits somewhere between eight and fifteen percent. That number matters because it shapes everything: recruiting, board dynamics, founder motivation through the brutal middle years, and ultimately whether an acquisition price that looks attractive on a headline basis actually delivers.

Where does the extra dilution come from? Three places, mostly.

First, bridge rounds. Defense tech companies bridge constantly. A program slips. A government customer takes six months longer than the contract modification suggested. Revenue didn't hit the milestone your Series B term sheet was tied to. These aren't failures of execution; they're features of the procurement environment. But each bridge carries warrants or converts at a discount, and they stack. A company that closes two bridges between Series A and Series B can shed another twelve to eighteen points of dilution that never showed up in anyone's original model.

Second, down rounds from hardware validation cycles. If your company builds physical systems, you already know the capital requirements are front-loaded in ways software investors genuinely don't internalize until they're on your board. Prototypes cost more than projected. Testing timelines stretch. The result is often a flat or down round at a moment when the company is actually de-risking technically. Founders who didn't negotiate broad-based weighted average anti-dilution provisions in earlier rounds get punished twice: by the lower valuation and by the ratchet mechanics of prior preferred.

Third, strategic investors taking above-market ownership for below-market value. This one is subtle. Government-adjacent strategics, including certain defense-focused family offices and prime contractor venture arms, often bring non-cash value: facility access, security clearances, government relationship leverage. Founders sometimes accept fifteen to twenty percent stakes at valuations that don't reflect the company's actual technical progress, rationalizing the strategic value. That rationalization gets expensive by the time the company is trying to raise a proper institutional round and the cap table looks messy.

So what should founders actually do?

Model dilution to exit from day one. Build a simple spreadsheet that walks through five to seven funding events and shows ownership at each stage under base, bridge-heavy, and down-round scenarios. Run this before you sign your first term sheet. The number most founders never calculate is their expected dollar outcome at a $300M acquisition versus a $500M one once you account for liquidation preferences and option pool refreshes. Sometimes the difference is smaller than expected. Sometimes it's the difference between life-changing and not.

Negotiate harder on pro-rata rights. In a sector where follow-on rounds are almost certain, pro-rata participation rights are one of the most valuable provisions a founder can push for on behalf of themselves and early angels. Preserving early ownership through disciplined follow-on is a better tool than fighting over pre-money valuation in a single round.

Be honest with your board about bridge risk before you need the bridge. Defense companies that have the bridge conversation in advance, when leverage still exists, tend to get cleaner terms than companies that come to their investors at ninety days of runway. This sounds obvious. Very few founders actually do it.

Finally, treat strategic investor negotiations as a separate category from financial investor negotiations. Strategics have different return profiles and different motivations. Price their equity accordingly. The clearance access is worth something. A shared facility is worth something. Quantify it, assign it a dollar value, and make sure that number is reflected in the deal structure rather than absorbed as goodwill you can't later monetize.

Defense tech's long game is real and it is genuinely worth playing. But playing it without understanding the dilution math means building something significant and walking away with a number that doesn't match the decade of work behind it. The companies that get this right aren't necessarily raising at higher valuations; they're just doing the arithmetic early enough to make decisions that compound in their favor.